Cellerant Therapeutics is a clinical-stage company developing innovative cell- and antibody-based immunotherapies.
Industries BiotechnologyClinical TrialsTherapeuticsHeadquarters Regions San Francisco Bay Area, Silicon Valley, West Coast Founded Date 2003 Founders Irving L. Weissman Operating Status Active Last Funding Type Grant Legal Name Cellerant Therapeutics, Inc.
Company Type For Profit
Contact Email info@cellerant.com Phone Number (650)232-2122
Cellerant Therapeutics is a clinical-stage company developing innovative cell- and antibody-based immunotherapies for hematologic malignancies and other blood-related disorders. Cellerant’s Romyelocel-L is a universal cell therapy that does not require HLA matching intended to prevent bacterial and fungal infections during neutropenia.
It was
founded in 2003 and headquartered in San Carlos, California.